X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23) 23
humans (22) 22
female (14) 14
oncology (13) 13
adult (11) 11
male (11) 11
middle aged (11) 11
aged (10) 10
lymphomas (10) 10
clinical trials (9) 9
cancer (8) 8
hematology (8) 8
chemotherapy (7) 7
treatment outcome (7) 7
article (6) 6
prognosis (6) 6
young adult (6) 6
aged, 80 and over (5) 5
b-cell lymphoma (5) 5
lymphoma (5) 5
adolescent (4) 4
analysis (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
care and treatment (4) 4
follow-up studies (4) 4
patients (4) 4
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - therapeutic use (3) 3
clinical trials as topic (3) 3
criteria (3) 3
diagnosis (3) 3
hematology, oncology and palliative medicine (3) 3
hodgkin lymphoma (3) 3
immunology (3) 3
internal medicine (3) 3
lymphocytes b (3) 3
lymphoma, large b-cell, diffuse - pathology (3) 3
medicine & public health (3) 3
methods (3) 3
neoplasms - drug therapy (3) 3
quality of life (3) 3
recurrence (3) 3
retrospective studies (3) 3
safety (3) 3
survival (3) 3
therapy (3) 3
toxicity (3) 3
transplantation (3) 3
abridged index medicus (2) 2
adults (2) 2
animals (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
biology (2) 2
cancer therapies (2) 2
case studies (2) 2
cell cycle checkpoints - drug effects (2) 2
central nervous system (2) 2
central nervous system relapse (2) 2
chemotherapy plus rituximab (2) 2
child (2) 2
cns relapse (2) 2
ctla-4 (2) 2
ctla4 (2) 2
development and progression (2) 2
diagnosis, differential (2) 2
diffuse large b-cell lymphoma (2) 2
distress (2) 2
drug therapy (2) 2
follicular lymphoma (2) 2
hematologic neoplasms - therapy (2) 2
hematopoietic stem cell transplantation (2) 2
hematopoietic stem cells (2) 2
immunotherapy (2) 2
impact (2) 2
lymphoma, large b-cell, diffuse - drug therapy (2) 2
lymphoma, large b-cell, diffuse - mortality (2) 2
medical oncology (2) 2
medical research (2) 2
medicine, experimental (2) 2
medicine, general & internal (2) 2
metastasis (2) 2
mutation (2) 2
neoplasm recurrence, local - pathology (2) 2
non-hodgkin lymphoma (2) 2
non-hodgkin-lymphoma (2) 2
non-hodgkins-lymphoma (2) 2
patient outcomes (2) 2
patient reported outcome measures (2) 2
patient-reported outcomes (2) 2
pd-1 (2) 2
phase-ii (2) 2
public health (2) 2
quality-of-life (2) 2
relapse (2) 2
research (2) 2
research design (2) 2
risk-factors (2) 2
rituximab (2) 2
survival analysis (2) 2
survival rate (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The FEBS Journal, ISSN 1742-464X, 06/2016, Volume 283, Issue 12, pp. 2233 - 2244
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. e264 - e265
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 09/2016, Volume 91, Issue 9, p. 1319
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 10/2015, Volume 107, Issue 10, p. 1
  A consistent system for reporting adverse events (AEs) is paramount in cancer clinical trials and is crucial to ensure the safety and tolerability of... 
Chemotherapy | Toxicity | Clinical trials | Oncology | Failure
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2017, Volume 179, Issue 1, pp. 50 - 60
Journal Article
Journal of Cancer Survivorship, ISSN 1932-2259, 6/2019, Volume 13, Issue 3, pp. 344 - 352
Journal Article
Nutrition and Cancer, ISSN 0163-5581, 10/2018, Volume 70, Issue 7, pp. 1088 - 1090
Dietary factors that may reduce the risk of relapse or prolong remission are an area of interest for patients with cancer. There is little data on the role of... 
RISK | NUTRITION & DIETETICS | EVENT-FREE SURVIVAL | ONCOLOGY | Diet | Lymphocytes B | Medical prognosis | Biomarkers | Risk reduction | Remission | Lymphomas | Lymphoma | Fatty acids | Patients | Cancer | B-cell lymphoma
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 10/2015, Volume 107, Issue 10, p. djv216
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e13083 - e13083
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5352 - 5352
Background Burkitt NHL (BL) is a rare hematologic malignancy that occurs in younger adults and is highly curable with aggressive chemoimmunotherapy induction... 
Journal Article
Current oncology reports, 10/2016, Volume 18, Issue 10, p. 61
Patient centeredness as the focus of healthcare delivery requires the incorporation of patient-reported outcomes into clinical trials. Clearly defining... 
Delivery of Health Care | Humans | Patient-Centered Care | Clinical Trials as Topic - methods | Research Design | Patient Reported Outcome Measures
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 6511 - 6511
Journal Article
Expert review of clinical immunology, 06/2016, Volume 12, Issue 6, p. 673
Hodgkin lymphoma's (HL) tumor composition is characterized by a paucity of malignant cells and a preponderance of immune and stromal cells. Despite the rich... 
Tumor Escape - drug effects | Growth Inhibitors - therapeutic use | Animals | Cell Cycle Checkpoints - drug effects | Humans | Hodgkin Disease - drug therapy | Tumor Microenvironment | Antineoplastic Agents - therapeutic use
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4157 - 4157
Abstract Background: Bortezomib has efficacy in follicular lymphoma (FL). Though generally well tolerated, it is associated with a few known toxicities,... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.